SOL Drug & Alcohol Services 2027

Old Value

New Value

Text

VI.3 Additional information: This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The publication of this notice marks the start of the standstill period. Representations by providers must be made to decision makers by midnight on Monday 7 September 2026. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR. Representations should be sent to the Corporate Procurement Service, Solihull MBC via email procteam@solihull.gov.uk The award decision-maker(s) were: Director of Public Health Declared conflicts or potential conflicts of interest of individuals: Conflicts of interest identified among service area officers: 1 potential perceived conflict of interest identified as 1 Council Officer involved in the process was employed by Provider five years previously but no connection since. The non-conflicted members have assessed the nature and risk of this conflict and have decided which steps to take to avoid or manage it: Clear contractual boundaries between commissioner and provider are in place and on-going. Contract management is also supported by another PH commissioner who has no affiliation with the service provider. Key criteria rationale: The relative importance of the key criteria is weighted to reflect that all key criteria are important to the successful delivery of the service, with a slightly higher weighting to key criteria 1, 3 and 4 as these are essential to a continued successful and responsive service.  Key criteria 5 (social value) was weighted 5 % in line with the existing contract. The existing provider is satisfying the original contract and will likely satisfy the proposed contract to a sufficient standard. Key criteria 1. Quality and innovation (25%) The provider delivers a broad range of evidence-based pharmacological and psychosocial interventions, tailored through needs and strengths-based assessments and co-produced recovery plans. Robust clinical governance supports safe delivery. A comprehensive harm reduction offer is in place. Performance is broadly stable with positive trajectories, including strong engagement, retention and above-average progress in treatment outcomes. Overall performance remains consistent and satisfactory, demonstrating sustained effectiveness. Future performance is expected to remain stable, effective, and progressively improving, supported by established systems and a strong platform for innovation. Key criteria 2. Value (20%) Delivery models prioritise efficiency and prevention. Available data indicates spend is broadly consistent with similar areas, with resources deployed effectively within the current financial envelope. The provider brings significant added value through long-standing relationships and integration across the local system. Key criteria 3. Integration, collaboration and service sustainability (25%) The provider's established system-wide visibility and referral pathways are well embedded across partner organisations. Flexible delivery models and integrated pathways are already in place and functioning effectively. Performance data shows strong rates of progression from referral to assessment, indicating that this model is supporting engagement and continuity. The provider performs particularly strongly in harm reduction. Overall, the provider is expected to deliver consistent, integrated, and sustainable services, with performance remaining stable and responsive despite increasing system pressures. Key criteria 4. Improving access, reducing health inequalities and facilitating choice (25%) The established model is embedded and functioning effectively. Performance data indicates strong conversion from referral to assessment, suggesting this approach will continue to support timely engagement. The provider demonstrates consistent use of data, needs assessment, and partner insight to target high-risk groups. The provider demonstrates a strong commitment to reducing inequalities through targeted interventions and co-production. This is supported by partnership working and monitoring processes, indicating sustained progress is likely. Key criteria 5. Social value (5%) Specific social value deliverables will be built upon through strengthening measurement and demonstrable impact.

Where

Section

VI.3.0.1

Label

Additional information: Date that representations by providers must be made. Amended to Midnight 7 September 2026